Document Detail


Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure.
MedLine Citation:
PMID:  20644005     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We test whether plasma level of methylglyoxal (MG) is an independent risk factor predicting the progression of diabetic macroangiopathy or microangiopathy in type 2 diabetic patients. We measured in 50 type 2 diabetic patients plasma levels of MG and 3-deoxyglucosone (DG) using an electrospray ionization-liquid chromatography-mass spectrometry. We assessed the correlations between baseline levels of MG or DG and the percentage changes after 5 years of clinical parameters linked to diabetic macroangiopathy or microangiopathy, that is, intima-media thickness (IMT), systolic blood pressure (SBP), the amount of urinary albumin excretion (ACR), pulse wave velocity (PWV), and estimated glomerular filtration rate (eGFR). Multiple regression analysis was performed using the percentage changes in IMT, SBP, ACR, PWV, and eGFR over the 5-year period as the independent or objective variables and the values of MG, DG, glycohemoglobin A1c, body mass index, triglyceride, and diabetic duration at the baseline as the dependent variables. The values of IMT, PWV, SBP, and ACR all increase, but eGFR reduces with time during the 5-year period. Baseline level of MG correlates significantly with the percentage changes of IMT, SBP, ACR, PWV, and eGFR, whereas that of DG does only with ACR. A multiple regression analysis reveals that MG is an independent risk factor for the percentage changes of IMT, PWV, and SBP but not for those of ACR and eGFR. DG is an independent risk factor for the percentage change of ACR. MG is a predictor in type 2 diabetic patients of intima-media thickening, of increase of PWV, and of elevation of SBP.
Authors:
Susumu Ogawa; Keisuke Nakayama; Masaaki Nakayama; Takefumi Mori; Masato Matsushima; Masashi Okamura; Miho Senda; Kazuhiro Nako; Toshio Miyata; Sadayoshi Ito
Related Documents :
12743615 - House dust and inorganic urinary arsenic in two arizona mining towns.
8250495 - The effect of microalbuminuria on glycaemic control, serum lipids and haemostasis param...
1889345 - Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with neph...
11472465 - Variability of glomerular filtration rate estimation using single injection methods in ...
17097645 - Il-1 receptor antagonist in metabolic diseases: dr jekyll or mr hyde?
2720975 - Concentrations of lipids and apolipoproteins in patients with clinically well-controlle...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-19
Journal Detail:
Title:  Hypertension     Volume:  56     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-19     Completed Date:  2010-09-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  471-6     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. ogawa-s@mail.tains.tohoku.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Blood Pressure
Body Weight
Diabetes Mellitus, Type 2 / blood*,  physiopathology*
Diabetic Angiopathies / blood,  physiopathology*
Humans
Hypertension / blood,  physiopathology*
Prospective Studies
Pyruvaldehyde / blood*
Regression Analysis
Risk Factors
Tunica Intima / physiopathology*
Tunica Media / physiopathology*
Chemical
Reg. No./Substance:
0/Biological Markers; 78-98-8/Pyruvaldehyde

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complexities of Defibrillator Deactivation.
Next Document:  Exercise Training and Caloric Restriction Prevent Reduction in Cardiac Ca2+-Handling Protein Profile...